10x Genomics, Inc. (TXG): Free Cash Flow
$130.12M
Year ended 2025-12-31
$121.44M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $130.12M | n/m | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | -$5.73M | n/m | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | -$63.80M | n/m | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | -$165.27M | n/m | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | -$122.65M | n/m | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | -$254.56M | n/m | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | -$8.12M | n/m | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | -$82.69M | n/m | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | -$14.46M | n/a | 2020-02-27, From 2017-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $130.12M | n/m |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | -$8.77M | n/m |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | -$113.92M | n/m |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $374.60M | +29.4% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $509.41M | -6.0% |
| Quanterix Corp (QTRX) | 2025-12-31 | -$79.85M | n/m |
| Waters Corp (WAT) | 2025-12-31 | $539.81M | -12.9% |
| Bruker Corp (BRKR) | 2025-12-31 | $43.30M | -68.2% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $848.65M | -1.8% |
Compare TXG, CTKB, PACB, BIO side by side · Screen every company in Laboratory Analytical Instruments ↗